BE
BE · BE · BE-AMP-SAM336813-00
Intanza 15 µg/strain
ATC J07BB02
Last synced from FAMHP / AFMPS (Belgium) on
Identification
ManufacturerSanofi Pasteur Europe
CountryBE (BE)
ATC codeJ07BB02
Dispensing—
ReimbursedNo
SourceFAMHP / AFMPS (Belgium)
Last synced6/13/2026
Packs · 2
- be_apb3260346
- be_apb0793877
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Suspension for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Intanza 15 µg/strain",
"name_fr": "Intanza 15 µg/souche",
"name_nl": "Intanza 15 µg/stam",
"amp_code": "SAM336813-00",
"strengths": null,
"pack_count": 3,
"substances": [
"Influenza Virus, Inactivated, Trivalent"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Influenza, Inactivated, Split Virus Or Surface Antigen",
"authorisation_numbers": [
"EU/1/08/505/005",
"EU/1/08/505/006"
]
}Related drugs
Other records sharing ATC code J07BB02.
- BEAdjupanrixGlaxoSmithKline Biologicals
- FIAdjupanrixGlaxoSmithKline Biologicals SA
- PLAdjupanrixGlaxoSmithKline Biologicals S.A.
- ISAdjupanrixGlaxoSmithKline Biologicals S.A.*
- DKAdjupanrixGlaxoSmithKline Biologicals S.A.
- CZADJUPANRIXGlaxoSmithKline Biologicals S.A., Rixensart
- IEAdjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)GlaxoSmithKline Biologicals S.A.
- NLAdjupanrix, (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals, suspensie en emulsie voor emulsie voor injectieGlaxoSmithKline Biologicals S.A.
Access this data programmatically
Query Intanza 15 µg/strain and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.